Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Hansen

Showing results (131-140 of 408) with videos related to

Pageof 41
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task ForceH H Hansen, M Bjerre-Jepsen, D Hossfeld
British Medical Journal|January 11, 1975
Letter: Forecasting subarachnoid haemorrhageB D Olivarius, M Buhl, H H Hansen
Ugeskrift for Laeger|March 19, 1984
[Treatment of extragonadal germinative tumors]K G Daugaard, M Rørth, H H Hansen
European Journal of Cancer & Clinical Oncology|March 1, 1983
Phase I evaluation of peplomycin with special reference to pulmonary toxicityP G Sørensen, M Rørth, H H Hansen
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lungH S Jensen, H H Hansen, P Dombernowsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Brain metastases in small-cell lung cancerU Lassen, P E Kristjansen, H H Hansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Systemic chemotherapy of brain metastases from small-cell lung cancer: a reviewC A Kristensen, P E Kristjansen, H H Hansen
Acta Radiologica: Oncology, Radiation, Physics, Biology|January 1, 1978
Relation between severity of thyrotoxicosis and response to 131I therapyK J Olsen, H E Nielsen, H H Hansen
Journal of Internal Medicine|August 1, 1995
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant diseaseJ B Sørensen, M K Andersen, H H Hansen
Gynecologic Oncology|July 1, 1997
Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinomaG Strauss, B Lund, M Hansen, et al.
Pageof 41

Showing results (131-140 of 408) with videos related to

Sort By:
Pageof 41
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task ForceH H Hansen, M Bjerre-Jepsen, D Hossfeld
British Medical Journal|January 11, 1975
Letter: Forecasting subarachnoid haemorrhageB D Olivarius, M Buhl, H H Hansen
Ugeskrift for Laeger|March 19, 1984
[Treatment of extragonadal germinative tumors]K G Daugaard, M Rørth, H H Hansen
European Journal of Cancer & Clinical Oncology|March 1, 1983
Phase I evaluation of peplomycin with special reference to pulmonary toxicityP G Sørensen, M Rørth, H H Hansen
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lungH S Jensen, H H Hansen, P Dombernowsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Brain metastases in small-cell lung cancerU Lassen, P E Kristjansen, H H Hansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Systemic chemotherapy of brain metastases from small-cell lung cancer: a reviewC A Kristensen, P E Kristjansen, H H Hansen
Acta Radiologica: Oncology, Radiation, Physics, Biology|January 1, 1978
Relation between severity of thyrotoxicosis and response to 131I therapyK J Olsen, H E Nielsen, H H Hansen
Journal of Internal Medicine|August 1, 1995
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant diseaseJ B Sørensen, M K Andersen, H H Hansen
Gynecologic Oncology|July 1, 1997
Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinomaG Strauss, B Lund, M Hansen, et al.
Pageof 41